What
Where
BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS TASK ORDER TITLE: COLORECTAL CANCER (CRC) PR...
From: Federal Procurement Data System(Federal)
 Basic Details |  Start Date11 Sep, 2023 (7 months ago) Due Date10 Sep, 2026 (in about 2 years) TypeContractIdentifier75N91019D00020 | ||||
 Customer / Agency | NATIONAL INSTITUTES OF HEALTH | ||||
Unlock the best of InstantMarkets.Please Sign In to see more out of InstantMarkets such as history, intelligent business alerts and many more.
Don't have an account yet? Create a free account now.
BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS TASK ORDER TITLE: COLORECTAL CANCER (CRC) PREVENTION BY TPST-1495 IN PIRC RAT MODEL Solicitation ID/Procurement Identifier: 75N91019D00020 Ultimate Completion Date: Thu Sep 10 17:00:00 GMT
Location
Address: 865 RESEARCH PKWY STE 530,OKLAHOMA CITY,OKLAHOMA,USA
Country : United StatesYou may also like
PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREVENTION OF ...
Due: 07 Jan, 2025 (in 8 months)MAINTENANCE SERVICES FOR ONE (1) BRUKER PRECLINICAL MRI SYSTEM USED BY THE CENTER FOR CANCER RESEARCH (CCR), RADIATION BIOLOGY BRANCH (RBB) IN PRE-CLINICAL BASI...
Due: 26 Apr, 2025 (in 11 months)PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM - A NOVEL MULTI-ANTIGEN VACCINE (TNBCVAX) TO PREVENT TRIPLE NEGATIVE BREAST CANCER
Due: 15 Sep, 2024 (in 4 months)Please Sign In to see more like these.
Don't have an account yet? Create a free account now.